InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.27
(
0.41%
)
Bitcoin
58,102.22
(
-3.42%
)
Post# of 163719
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HighYield1

Send PM Follow Ignore
Followers 1
Posts 110
Boards Moderated 0
Alias Born 05/17/2013

HighYield1

Re: RealDutch post# 69568

Friday, 08/22/2014 4:11:15 AM

Friday, August 22, 2014 4:11:15 AM

Post# of 163719
RD, I had a quick look at HERB's latest 10Q filing. I have not looked at HERB before, and at first glance the Company looks very attractive in terms of valuation.

However, I noticed that sales and operating expenses for all the different subsidiaries had increased by same pace (9,4%)compared to a year ago. This is very unlikely, and a clear red flag. Page 13 note 11 in the 10Q filing.


http://www.sec.gov/Archives/edgar/data/1123312/000119983514000413/yasheng_10q-16106.htm
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up